Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

Background. There is not yet an agreed adjuvant treatment for melanoma patients with American Joint Committee on Cancer stages III B and C. We report administration of an autologous melanoma vaccine to prevent disease recurrence. Patients and Methods. 126 patients received eight doses of irradiated...

詳細記述

保存先:
書誌詳細
出版年:J Immunol Res
主要な著者: Lotem, Michal, Merims, Sharon, Frank, Stephen, Hamburger, Tamar, Nissan, Aviram, Kadouri, Luna, Cohen, Jonathan, Straussman, Ravid, Eisenberg, Galit, Frankenburg, Shoshana, Carmon, Einat, Alaiyan, Bilal, Shneibaum, Shlomo, Ozge Ayyildiz, Zeynep, Isbilen, Murat, Mert Senses, Kerem, Ron, Ilan, Steinberg, Hanna, Smith, Yoav, Shiloni, Eitan, Gure, Ali Osmay, Peretz, Tamar
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2016
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887652/
https://ncbi.nlm.nih.gov/pubmed/27294163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/8121985
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料